Welcome: Guest | Site Use Options | Register | Login |

P2D Bioscience

P2D Bioscience

Profile last edited on: 11/18/2019
10101 Alliance Road Suite 105
Cincinnati, OH 45242
  (513) 475-6618
  rmoconnor@p2dinc.com
  www.p2dinc.com
Business Identifier: Treatments for central nervous system (CNS) inflammatory disorders such as Dementia and Alzheimer's
Public Profile:
P2D Bioscience is strucured around developiment of treatments for central nervous system (CNS) inflammatory disorders such as Frontotemporal Dementia (FTD) and Alzheimer's disease (AD). Utilizing a targeted phenotypic screening approach and transgenic preclinical models of neurodegenerative diseases in order to accelerate the drug development process, P2D's goal to advance a product candidate through preclinical efficacy testing, GLP-safety studies and early clinical safety and clinical proof-of-concept studies then seek partners to complete the clinical development and commercialization process. The company's pipeline of drug candidates are 1) orally and centrally active isoindoline TNF? inhibitors for the treatment FTD and AD and 2) benztropine-analog DAT inhibitors for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

WikiProfile

Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com